维普中文期刊产品整合服务
18篇 您的检索式:作者名="MARCHION DC"
    题名 作者 年代 出处 被引量
1Selective inhibition of histone deacetylase 2 silences progesteronereceptor-mediated signaling显示文摘Bicaku E Marchion DC Schrnitt ML 2008Cancer Res2008,68,5:1
2Degradation of HER2 by ansamycins induces growth arrest and apoptosis in cells with HER2 overexpression via a HER3, phosphatidylinositol 3Vkinase- AKT-dependent pathway 显示文摘Munster PN Marchion DC Basso AD 2002Cancer Res2002,62,:1
3Selective inhibi- tion of histone deacetylase 2 silences progesterone recep- tor-mediated signaling显示文摘Bicaku E Marchion DC Schmitt ML etal 2008Cancer Res2008,,68:1
4Valproic acid alters chromatin structure by regulation of chromatin modulation proteins显示文摘Marchion DC Bicaku E Daud AI 2005Cancer Res2005,65,9:1
5BAD phos- phorylation determines ovarian cancer chemosensitivity and patient survival 显示文摘Marchion DC Cottrill HM Xiong Y 2011Clin Cancer Res2011,17,:1
6BAD pho- sphorylation determines ovarian cancer ehemosensitivity and patient survival显示文摘Marchion DC Cottril HM Xiong Y 2011Clin Cancer Res2011,17,19:1
7In vivo synergy between topoisomerase Ⅱ and histone deacetylase inhibitors: predictive correlates显示文摘Marchion DC Bicaku E Daud AI 2005Mol Cancer Ther2005,4,12:1
8Valproic acid alters chromatin structure by regulation of chromatin modulation proteins 显示文摘Marchion DC Bicaku E Daud AI 2005Cancer Res2005,65,9:1
9Valproic acid alters chromatin structure by regulation of chromatin modulation proteins显示文摘Marchion DC Bicaku E Daud AI Sullivan DM Munster PN 2005Cancer Res2005,65,9:1
10Synergistic interac- tion between histone deacetylase and topoisomerase Ⅱ inhibi- tors is mediated through topoisomerase Ⅱβ显示文摘Marchion DC Bicaku E Turner JG 2005Clin Cancer Res2005,11,23:1
11An in vitro model of pericardial tissue healing显示文摘MARCHION DC PFAU J C WEBER P A 2003Biomaterials2003,24,1:1
12BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivi- ty to cisplatin 显示文摘Bansal N Marchion DC Bieaku E 2012J Gynecol Oncol2012,23,1:1
13Selective inhibi- tion of histone deacetylase 2 silences progesterone receptor-medi- ated signaling 显示文摘Bicaku E Marchion DC Schmitt ML 2008Cancer Res2008,68,5:1
14Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cispla- tin-induced growth arrest 显示文摘A1 Sawah E Chen X Marchion DC 2013Gynecol Oneol2013,131,1:1
15Selective inhibition of histone deacetylase2 silences progesterone receptor-mediated signa- ling 显示文摘Biqaku E Marchion DC Schmitt ML 2008Cancer Res2008,68,5:1
16BAD phosphorylation determines ovarian cancer chemosensitivity and patient survival显示文摘Marchion DC Cottrill HM Xiong Y 2011Clin Cancer Res2011,17,:1
17Valproic acid alters chromatin structure by regulation of chromatin modulation proteins显示文摘Marchion DC Bicaku E Daud AI 2005Cancer Res2005,65,9:1
18Bad-mediated apoptotic pathway is associated with human cancer development显示文摘Stickles XB Marchion DC Bicaku E 2015IntJ Mol Med2015,35,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费